EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nova Eye Medical's Enterprise Value is $44.28 Mil.
Nova Eye Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.67 Mil. Therefore, Nova Eye Medical's EV-to-FCF for today is -9.49.
The historical rank and industry rank for Nova Eye Medical's EV-to-FCF or its related term are showing as below:
ELXMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -98.21 Med: -10.54 Max: 96.59
Current: -7.36
During the past 13 years, the highest EV-to-FCF of Nova Eye Medical was 96.59. The lowest was -98.21. And the median was -10.54.
ELXMF's EV-to-FCF is ranked worse than 100% of 361
companies
in the Medical Devices & Instruments industry
Industry Median: 28.3
vs ELXMF: -7.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Nova Eye Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nova Eye Medical's EV-to-FCF
For the Medical Devices subindustry, Nova Eye Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Eye Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nova Eye Medical's EV-to-FCF falls into.
Nova Eye Medical's current Enterprise Value is $44.28 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Eye Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Eye Medical (OTCPK:ELXMF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Nova Eye Medical's PE Ratio for today is calculated as:
Nova Eye Medical's share price for today is $0.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Eye Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.054.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nova Eye Medical EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Nova Eye Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Nova Eye Medical (Nova Eye Medical) Business Description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELXMF has been successfully added to your 